Wu, Y.; Pfeifer, A.K.; Myschetzky, R.; Garbyal, R.S.; Rasmussen, P.; Knigge, U.; Bzorek, M.; Kristensen, M.H.; Kjaer, A.
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor. Diagnostics 2013, 3, 344-355.
https://doi.org/10.3390/diagnostics3040344
AMA Style
Wu Y, Pfeifer AK, Myschetzky R, Garbyal RS, Rasmussen P, Knigge U, Bzorek M, Kristensen MH, Kjaer A.
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor. Diagnostics. 2013; 3(4):344-355.
https://doi.org/10.3390/diagnostics3040344
Chicago/Turabian Style
Wu, Yin, Andreas Klaus Pfeifer, Rebecca Myschetzky, Rajendra Singh Garbyal, Palle Rasmussen, Ulrich Knigge, Michael Bzorek, Michael Holmsgaard Kristensen, and Andreas Kjaer.
2013. "Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor" Diagnostics 3, no. 4: 344-355.
https://doi.org/10.3390/diagnostics3040344
APA Style
Wu, Y., Pfeifer, A. K., Myschetzky, R., Garbyal, R. S., Rasmussen, P., Knigge, U., Bzorek, M., Kristensen, M. H., & Kjaer, A.
(2013). Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor. Diagnostics, 3(4), 344-355.
https://doi.org/10.3390/diagnostics3040344